Description
BSE lists 9,32,384 new equity shares of Trident Texofab Limited issued through warrant conversion, effective August 4, 2025.
Summary
BSE has approved the listing of 9,32,384 new equity shares of Trident Texofab Limited (Scrip Code: 540726) issued through conversion of warrants on a preferential basis to non-promoters. The shares will commence trading on August 4, 2025.
Key Points
- 9,32,384 equity shares of Rs. 10/- each issued at premium of Rs. 60/- per share
- Issue price: Rs. 70/- per share
- Shares issued to non-promoters on preferential basis pursuant to warrant conversion
- New shares rank pari-passu with existing equity shares
- ISIN: INE071Y01013
- Distribution numbers: 14063381 to 14995764
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
- Trading members informed of new securities listing
- Lock-in period applicable until February 5, 2026 for all new shares
- Standard trading and settlement procedures apply
Important Dates
- Allotment Date 1: May 29, 2025 (4,50,477 shares)
- Allotment Date 2: June 4, 2025 (4,81,907 shares)
- Trading Commencement: August 4, 2025
- Lock-in Expiry: February 5, 2026
Impact Assessment
Minimal market impact expected as this represents a routine listing of shares issued through warrant conversion. The lock-in period until February 2026 prevents immediate liquidity impact. The preferential allotment to non-promoters may provide some additional float in the market post lock-in expiry.
Impact Justification
Routine listing of new shares through warrant conversion with limited market impact